In addition, exogenous TGF-β1 treatment partially reversed the inhibitory effects of overexpression of lncRNA HAND2-AS1 on cancer cell migration (Figure 4A, P<0.05) and invasion (Figure 4B, P<0.05). This evidence concerns the gene TGFB1 and cancer.